Fimasartan and Rosuvastatin for Hypertension and Dyslipidemia Control

Inclusion Criteria

• •Hypertension patients who are taking an anti-hypertensive agent, including Fimasartan at least 12 weeks or more.
• •Dyslipidemia patients who are taking dyslipidemia drug, including Rosuvastatin at least 12 weeks or more
• •Patients who has blood pressure and lipid levels (Total cholesterol, LDL-C, HDL-C, non-HDL-C, \* TG) checks 2 weeks before registration